These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29710714)

  • 1. The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.
    Wimo A
    J Alzheimers Dis; 2018; 64(s1):S41-S46. PubMed ID: 29710714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.
    Wimo A; Ballard C; Brayne C; Gauthier S; Handels R; Jones RW; Jonsson L; Khachaturian AS; Kramberger M
    J Intern Med; 2014 Mar; 275(3):304-16. PubMed ID: 24605810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Impact of Alzheimer's Disease Early Treatment on Societal Costs of Care in Czechia: A Simulation Approach.
    Broulikova HM; Sladek V; Arltova M; Cerny J
    J Ment Health Policy Econ; 2018 Dec; 21(4):147-161. PubMed ID: 30676992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Disease-Modifying Treatments in Alzheimer's Disease - A Perspective from Roche and Genentech.
    Doody R
    J Prev Alzheimers Dis; 2017; 4(4):264-272. PubMed ID: 29181492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):683-695. PubMed ID: 28490260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?
    Monien BH; Apostolova LG; Bitan G
    Expert Rev Neurother; 2006 Sep; 6(9):1293-306. PubMed ID: 17009917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's disease from Auguste Deter to the present : Progress, disappointments and open questions].
    Pantel J
    Z Gerontol Geriatr; 2017 Oct; 50(7):576-587. PubMed ID: 28924872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.
    Cummings J; Ritter A; Zhong K
    J Alzheimers Dis; 2018; 64(s1):S3-S22. PubMed ID: 29562511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies.
    Wiltfang J; Esselmann H; Maler JM; Bleich S; Hüther G; Kornhuber J
    Gerontology; 2001; 47(2):65-71. PubMed ID: 11287729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and treatment for Alzheimer's disease: predicting population-level outcomes.
    Furiak NM; Kahle-Wrobleski K; Callahan C; Klein TM; Klein RW; Siemers ER
    Alzheimers Dement; 2012 Jan; 8(1):31-8. PubMed ID: 22265589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
    Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
    J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Gustavsson A; Green C; Jones RW; Förstl H; Simsek D; de Reydet de Vulpillieres F; Luthman S; Adlard N; Bhattacharyya S; Wimo A
    Alzheimers Dement; 2017 Mar; 13(3):312-321. PubMed ID: 28063281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
    Bjerke M; Engelborghs S
    J Alzheimers Dis; 2018; 62(3):1199-1209. PubMed ID: 29562530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Registries to Boost the Clinical Trials for the Disease Modifying Therapy of Alzheimer's Disease].
    Akiyama H
    Brain Nerve; 2017 Jul; 69(7):743-748. PubMed ID: 28739987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.